Patents by Inventor Zongdong Li

Zongdong Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8753631
    Abstract: The present invention is directed to a therapeutic agent comprising a GPIIIa(49-66) specific targeting agent and a thrombi-specific homing agent. Also disclosed is the use of the therapeutic agent in carrying out a method of treating thromboembolic disorders and a method of inducing platelet fragmentation.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: June 17, 2014
    Assignee: New York University
    Inventors: Simon Karpatkin, Michael Nardi, Zongdong Li
  • Publication number: 20110287045
    Abstract: The present invention relates to the discovery that Tat polypeptides may be used as immunoregulators to enhance the immune response to infectious diseases. More particularly, Tat polypeptides may be used as immunoregulators to enhance immune responses to microbial infections, for example, viral and bacterial infections. In accordance with the present invention, Tat polypeptides interact with CCR3 to stimulate platelet activation. The novel finding of the present inventors, therefore, presents new applications for which Tat nucleic and amino acid sequences, and compositions thereof may be used to advantage. Applications for which the Tat nucleic and amino acid sequences and compositions thereof of the invention may be used include, but are not limited to, various research and therapeutic applications as described herein. Also provided is a kit comprising Tat nucleic and/or amino acid sequences, Tat activity compatible buffers, and instruction materials.
    Type: Application
    Filed: May 19, 2011
    Publication date: November 24, 2011
    Inventor: Zongdong Li
  • Publication number: 20110045008
    Abstract: The present invention is directed to a therapeutic agent comprising a GPIIIa(49-66) specific targeting agent and a thrombi-specific homing agent. Also disclosed is the use of the therapeutic agent in carrying out a method of treating thromboembolic disorders and a method of inducing platelet fragmentation.
    Type: Application
    Filed: April 30, 2010
    Publication date: February 24, 2011
    Applicant: NEW YORK UNIVERSITY
    Inventors: Simon Karpatkin, Magaret Karpatkin, Michael Nardi, Zongdong Li